by MM360 Staff | Jan 17, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by Marisa Wexler, MS | Jan 16, 2026 | Myeloma News
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to NP-G2-044, an experimental treatment for pancreatic cancer that’s currently in clinical testing. The FDA gives this designation to investigational medicines intended to treat conditions...
by MM360 Staff | Jan 16, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jan 16, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jan 16, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jan 16, 2026 | Myeloma News
Source: Pharmacy Times articles Post Content Read More